Verve Ventures

2Exits tracked$800mDisclosed value$800mMedian price0Acquihires

Startups backed by Verve Ventures that were acquired: 2 exits so far, with the buyer, the price where disclosed and every source.

Photo: Rhoda Baer (Photographer) / Wikimedia Commons, Public domain

Healthtech & bio · Schlieren

Ipsen to buy Swiss biotech Memo Therapeutics for €200 million upfront plus milestones

The French drugmaker is paying for one asset: potravitug, a Phase II antibody against BK polyomavirus in kidney-transplant patients. Memo's discovery platform and other staff are being split off into a new company its shareholders keep.

Price$800mRaisedn/aLast stageSeries CBuyer typeCorporate

Latest in Verve VenturesFrance · ProptechOtis takes majority stake in WeMaintain, a French elevator-maintenance start-upUndisclosedStage n/a13 Apr

All Verve Ventures exitsOpen tracker →

1 JulIpsen → Memo TherapeuticsSchlieren · Series C · raised n/a$800m$250m–1bn 13 AprOtis → WeMaintainFrance · Stage n/a · raised $45mUndisclosedUndisclosed